These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 26619914)
1. The Role of Renin Angiotensin Aldosterone System Genes in Diabetic Nephropathy. Rahimi Z Can J Diabetes; 2016 Apr; 40(2):178-83. PubMed ID: 26619914 [TBL] [Abstract][Full Text] [Related]
2. Renin Angiotensin Aldosterone System (RAAS): its biology and drug targets for treating diabetic nephropathy. Zain M; Awan FR Pak J Pharm Sci; 2014 Sep; 27(5):1379-91. PubMed ID: 25176370 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage? Lely AT; Luik PT; Navis G Curr Diabetes Rev; 2007 Feb; 3(1):41-52. PubMed ID: 18220655 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy. Rahimi Z; Moradi M; Nasri H J Res Med Sci; 2014 Nov; 19(11):1090-8. PubMed ID: 25657757 [TBL] [Abstract][Full Text] [Related]
5. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684 [TBL] [Abstract][Full Text] [Related]
6. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone. Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735 [TBL] [Abstract][Full Text] [Related]
8. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis. Smyth LJ; Cañadas-Garre M; Cappa RC; Maxwell AP; McKnight AJ BMJ Open; 2019 May; 9(4):e026777. PubMed ID: 31048445 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy. Tamura J; Konno A; Hashimoto Y; Kon Y Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318 [TBL] [Abstract][Full Text] [Related]
10. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002 [TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease. Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556 [TBL] [Abstract][Full Text] [Related]
12. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. Prasad P; Tiwari AK; Kumar KM; Ammini AC; Gupta A; Gupta R; Sharma AK; Rao AR; Nagendra R; Chandra TS; Tiwari SC; Rastogi P; Gupta BL; Thelma BK BMC Med Genet; 2006 May; 7():42. PubMed ID: 16672053 [TBL] [Abstract][Full Text] [Related]
13. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204 [TBL] [Abstract][Full Text] [Related]
14. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope! Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084 [TBL] [Abstract][Full Text] [Related]
15. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Rudnicki M; Mayer G Pharmacogenomics; 2009 Mar; 10(3):463-76. PubMed ID: 19290794 [TBL] [Abstract][Full Text] [Related]
16. Update on role of direct renin inhibitor in diabetic kidney disease. Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880 [TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin-aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients. Mtiraoui N; Ezzidi I; Turki A; Chaieb M; Mahjoub T; Almawi WY J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):572-80. PubMed ID: 21421655 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the renin-angiotensin system genes and diabetic nephropathy in the Chinese. Wu S; Xiang K; Zheng T; Sun D; Weng Q; Zhao H; Li J Chin Med J (Engl); 2000 May; 113(5):437-41. PubMed ID: 11776100 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation with calcitriol for reducing urinary angiotensinogen in patients with type 2 diabetic chronic kidney disease. Tiryaki Ö; Usalan C; Sayiner ZA Ren Fail; 2016; 38(2):222-7. PubMed ID: 26707134 [TBL] [Abstract][Full Text] [Related]
20. Association of polymorphisms in angiotensin and aldosterone synthase genes of the renin-angiotensin-aldosterone system with high-altitude pulmonary edema. Srivastava S; Bhagi S; Kumari B; Chandra K; Sarkar S; Ashraf MZ J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):155-60. PubMed ID: 22156739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]